Sharon Passe

2.8k total citations · 1 hit paper
31 papers, 2.1k citations indexed

About

Sharon Passe is a scholar working on Genetics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sharon Passe has authored 31 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 10 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sharon Passe's work include Chronic Lymphocytic Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Sharon Passe is often cited by papers focused on Chronic Lymphocytic Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Sharon Passe collaborates with scholars based in United States, Switzerland and Germany. Sharon Passe's co-authors include Francesca J. Torriani, Franck Le Duff, Douglas T. Dieterich, Christine Katlama, Giampiero Carosi, M. Rodríguez‐Torres, Hoel Sette, Eduardo Lissen, Joseph Sasadeusz and Adriano Lazzarin and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Sharon Passe

30 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients

2004 953 citations Francesca J. Torriani, M. Rodríguez‐Torres et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharon Passe United States	18	1.0k	906	414	333	327	31	2.1k
Der‐Cherng Liang Taiwan	21	944 0.9×	1.2k 1.3×	156 0.4×	175 0.5×	645 2.0×	81	2.6k
W. David Lewis United States	29	1.5k 1.4×	1.1k 1.2×	276 0.7×	92 0.3×	66 0.2×	73	3.3k
François Lefrère France	26	503 0.5×	362 0.4×	247 0.6×	818 2.5×	1.1k 3.2×	79	2.9k
G C de Gast Netherlands	22	238 0.2×	656 0.7×	141 0.3×	139 0.4×	259 0.8×	58	1.6k
Florian Emmerich Germany	23	393 0.4×	412 0.5×	166 0.4×	214 0.6×	201 0.6×	59	2.7k
Christoph Kahl Germany	26	234 0.2×	287 0.3×	198 0.5×	129 0.4×	206 0.6×	96	1.9k
Diane C. Farhi United States	20	111 0.1×	465 0.5×	283 0.7×	180 0.5×	270 0.8×	45	1.4k
Noemi Corbetta Italy	9	225 0.2×	262 0.3×	730 1.8×	206 0.6×	354 1.1×	16	2.7k
Marshall T. Schreeder United States	27	327 0.3×	360 0.4×	86 0.2×	675 2.0×	252 0.8×	103	2.1k
Luís Bianchi Spain	23	1.5k 1.5×	1.1k 1.2×	368 0.9×	30 0.1×	82 0.3×	53	2.8k

Countries citing papers authored by Sharon Passe

Since Specialization

Citations

This map shows the geographic impact of Sharon Passe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Passe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Passe more than expected).

Fields of papers citing papers by Sharon Passe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Passe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Passe. The network helps show where Sharon Passe may publish in the future.

Co-authorship network of co-authors of Sharon Passe

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Passe. A scholar is included among the top collaborators of Sharon Passe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Passe. Sharon Passe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grippo, Joseph F., et al.. (2021). Safety, tolerability, pharmacokinetics, and pharmacodynamics of a TLR7 agonist prodrug RO6870868 in healthy volunteers. Clinical and Translational Science. 14(4). 1524–1534. 6 indexed citations

Shapiro, Geoffrey I., Patricia LoRusso, Afshin Dowlati, et al.. (2020). A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma. British Journal of Cancer. 124(4). 744–753. 83 indexed citations

Caimi, Paolo F., Joseph P. Eder, Eric D. Jacobsen, et al.. (2017). A PHASE 1 STUDY OF BET INHIBITION USING RG6146 IN RELAPSED/REFRACTORY (R/R) MYC‐EXPRESSING DIFFUSE LARGE B CELL LYMPHOMA (DLBCL). Hematological Oncology. 35(S2). 263–265. 3 indexed citations

Passe, Sharon, et al.. (2008). A Phase II Study of the Purine Nucleoside Phosphorylase (PNP) Inhibitor RO5092888 (BCX-4208) in Patients with Moderate to Severe Chronic Plaque Psoriasis: Safety, Tolerability and Lymphocyte Effects. Blood. 112(11). 2583–2583. 1 indexed citations

Torriani, Francesca J., M. Rodríguez‐Torres, Jürgen K. Rockstroh, et al.. (2004). Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients. New England Journal of Medicine. 351(5). 438–450. 953 indexed citations breakdown →

Mauss, Stefan, William M. Valenti, Jean DePamphilis, et al.. (2004). Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy. AIDS. 18(13). 21–25. 123 indexed citations

Dupont, Jakob, Carol Aghajanian, S. Pezzulli, et al.. (2004). Phase I and Pharmacokinetic Study of the Novel Oral Cell-Cycle Inhibitor Ro 31-7453 in Patients With Advanced Solid Tumors. Journal of Clinical Oncology. 22(16). 3366–3374. 12 indexed citations

Kim, Jeri, et al.. (1998). Pharmacokinetics of recombinant human interferon ??2a combined with 5-fluorouracil in patients with advanced colorectal carcinoma. Anti-Cancer Drugs. 9(8). 689–696. 5 indexed citations

Passe, Sharon, et al.. (1996). The Effect of Probenecid on the Pharmacokinetics of Zalcitabine in HIV-Positive Patients. Pharmaceutical Research. 13(3). 449–452. 20 indexed citations

10.

Zhi, Jianguo, Angela T. Melia, Roberto Guerciolini, et al.. (1996). The Effect of Orlistat on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Volunteers. The Journal of Clinical Pharmacology. 36(7). 659–666. 36 indexed citations

11.

Melia, Angela T., et al.. (1995). The Influence of Reduced Dietary Fat Absorption Induced by Orlistat on the Pharmacokinetics of Digoxin in Healthy Volunteers. The Journal of Clinical Pharmacology. 35(8). 840–843. 34 indexed citations

12.

Passe, Sharon, et al.. (1995). The Effect of Food on Pharmacokinetics of Zalcitabine in HIV-Positive Patients. Pharmaceutical Research. 12(10). 1462–1465. 19 indexed citations

13.

Passe, Sharon, et al.. (1991). The effects of cimetidine and ranitidine on the pharmacokinetics of cifenline.. British Journal of Clinical Pharmacology. 31(4). 481–483. 3 indexed citations

14.

Reele, Stots B., et al.. (1988). The effect of trimoprostil (trimethyldesoxy prostaglandin E2) on the intrauterine pressure in women. Clinical Pharmacology & Therapeutics. 44(2). 179–185. 1 indexed citations

15.

MacEwen, E. Gregory, Audrey A. Hayes, Hugh Harvey, et al.. (1984). Prognostic factors for feline mammary tumors. Journal of the American Veterinary Medical Association. 185(2). 201–204. 70 indexed citations

16.

Castro‐Malaspina, Hugo, G Schaison, Sharon Passe, et al.. (1984). Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Clinical and hematologic observations, and identification of prognostic factors. Cancer. 54(4). 675–686. 120 indexed citations

17.

Cw, Young, Jane Myers, Sharon Passe, et al.. (1982). Multidisciplinary treatment of advanced Hodgkin's disease by an alternating chemotherapeutic regimen of MOPP/ABDV and low-dose radiation therapy restricted to originally bulky disease.. PubMed. 66(4). 907–14. 7 indexed citations

18.

MacEwen, E. Gregory, Nancy O. Brown, Amiya K. Patnaik, Audrey A. Hayes, & Sharon Passe. (1981). Cyclic Combination Chemotherapy of Canine Lymphosarcoma. Journal of the American Veterinary Medical Association. 178(11). 1178–1181. 77 indexed citations

19.

Mertelsmann, Roland, Toby Gee, Sanford Kempin, et al.. (1981). Treatment of acute nonlymphocytic leukemia in adults: Response to 2,2-anhydro-1-B-D-Arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocol. Cancer. 48(10). 2136–2142. 10 indexed citations

20.

Schneider, Robert J., Katherine Seibert, Sharon Passe, et al.. (1980). Prognostic significance of serum lactate dehydrogenase in malignant lymphoma. Cancer. 46(1). 139–143. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact